You have no items in your shopping cart.
SARS-CoV-2 (COVID-19) Spike RBD Neutralizing Antibody [C-A11]
Description
Images & Validation
−| Tested Applications | FC, NeA |
|---|---|
| Reactivity | Virus |
| Application Notes |
Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Host | Rabbit |
| Clonality | Recombinant |
| Isotype | IgG1k |
| Clone No. | C-A11 |
| Immunogen | recombinant protein (RBD) |
| Target | S |
| Purification | Protein A |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| Form/Appearance | Liquid |
| Buffer/Preservatives | 1X PBS |
| Concentration | batch dependent |
| Disclaimer | For research use only |
Alternative Names
−
Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.
![SARS-CoV-2 (COVID-19) Spike RBD Neutralizing Antibody [C-A11]](/images/pub/media/catalog/product/NewWebsite/15/orb1274601_1.jpg)
Flow cytometry neutralizing assay: C-A11 displayed dose dependent blocking of spike proteins (wild type and UK variant) to ACE2 expressing cells.
![SARS-CoV-2 (COVID-19) Spike RBD Neutralizing Antibody [C-A11]](/images/pub/media/catalog/product/NewWebsite/15/orb1274601_2.jpg)
Affinity assessment of SARS-CoV-2 C-A11 IgG to wild type and B.1.1.7 (UK) S1+S2 trimers. C-A11 possesses very low (pM) KD affinity to both variants.
![SARS-CoV-2 (COVID-19) Spike RBD Neutralizing Antibody [C-A11]](/images/pub/media/catalog/product/NewWebsite/15/orb1274601_3.jpg)
Flow cytomery neutralizing assay of C-A11 (plotted graphs): ACE2 transfected cells were incubated with biotinylated spike protein (0.5 ug/mL) in the presence or absence of antibody. Binding of spike protein was detected with DyLight488 conjugated StreptAvidin. C-A11 efficiently blocked the binding of wild type and UK variant (B.1.1.7) to ACE2 expressing HEK293 cells.
![SARS-CoV-2 (COVID-19) Spike RBD Neutralizing Antibody [C-A11]](/images/pub/media/catalog/product/NewWebsite/15/orb1274601_4.jpg)
Binding of C-A11 to SARS-CoV-2 variants (UK and South Africa): C-A11 shows good cross reactivity to both variants B.1.1.7 (UK) and B.1.351 (S. Africa).
Documents Download
Request a Document
SARS-CoV-2 (COVID-19) Spike RBD Neutralizing Antibody [C-A11] (orb1274601)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review